At 3 months , the PRISM-JP ( n = 26 ) participants did significantly better compared to the C-JP participants ( n = 27 ) in JP behaviour ( p = 0.02 and p = 0.008 when corrected for baseline values ) , Arthritis Self-efficacy ( ASES , p = 0.015 ) and JP self-efficacy ( JP-SES , p = 0.047 ) .
